HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

International Summit on Hematology and Blood Disorders

October 17-18, 2022 | Orlando, USA

October 17 -18, 2022 | Orlando, Florida, USA

About Hematology 2022

Magnus Group Conferences is glad to introduce the International Summit on Hematology and Blood disorders (Hematology 2022) taking place at Orlando, USA during October 17-18, 2022.

ISHB 2022 is scheduled in Hybrid Format with both onsite and virtual versions. We believe that our decision will enable broad participation.

Hematology 2022 typically incorporate invited lectures, paper and poster sessions and panel sessions with prominent international experts and scholars. It also features product exhibitions, workshops/symposiums that generate networking opportunities for all participants. It attracts attendees from around the globe to meet with colleagues, discover innovative trends and address persistent issues in the Hematology field.

Theme: Transfusing Innovations and Exploring Emerging Concepts in Hematology

The aim of this two-day event is to promote the advancement of the rapidly developing technology in this field. Innovative ideas are thrown about and new information is switched among experts. You have the greatest chance of exposing yourself to a world of examining and its importance like never before.

Come, be a part of the conference!

Recommended: Hematology Conferences 2022 | International Hematology ConferencesBlood Conferences 2022 | ISHB 2022 | Hematology Congress


Get news, updates, and more from the Conference.

Antispam Code Generate new code

By submitting this form, you are consenting to receive emails and notifications from Magnus Group. You can revoke your consent to receive emails at any time by using the Safe Unsubscribe link, found at the bottom of every email.

Past Conference Information

3rd Edition of Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2019) Report:

Magnus Group successfully completed 3rd Edition of Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2019) at Paris, France during June 24-26, 2019.

Day 1:  June 24, 2019 (Monday)

The conference was initiated by Moderator Fabien Gosselet from Blood-brain barrier laboratory, Artois University, France with the Honourable presence of the Keynote forum. The list includes:

Vladimir P. Torchilin, Northeastern University, USA
Robert Houlden, Formulytica Pty. Ltd, Australia
Robert P. Bianchi, Prescription Drug Research Center, USA
Georgina Kate Such, University of Melbourne, Australia

Oral Presentations were held on Novel Developments In Drug Delivery SystemFormulation TechnologiesAdvanced Drug Delivery SystemsDrug Delivery Through BBBBiodrugs, Biomolecules and Therapeutics Session under the guidance of Session chairs. 

Day 1 Speakers with their Presentation Details:

Title: Docetaxel-liposomes prepared by the dual centrifugation method: Effect of propylene glycol and lipid charge on liposomal characteristics
Ann Mari Holsæter, The Arctic University of Norway, Norway
Title: Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments
Jan Tavernier, UGent/VIB, Belgium
Title: Lipid and carbohydrate based delivery vesicles for gene therapeutics: Approaching difficult diseases
Kira Astakhova, Technical University of Denmark, Denmark
Title: In vitro modeling of the blood-brain barrier to assess CNS drug delivery
Fabien Gosselet, Blood-brain barrier laboratory, Artois University, France
Title: Prototyping and evaluating a novel humanoid chewing robot for drug delivery using a medicated chewing gum
Kazem Alemzadeh, University of Bristol, UK
Title: Multifunctionalized and targeted biocatalytic nanoreactor for combinatory treatment of ER+ breast cancer
Rafael Vazquez-Duhalt, Universidad Nacional Autónoma de México, Mexico
Title: New approach to study difference in NSAIDs enantiomer activity, including chiral inversion
Tatyana Viktorovna Leshina, Voevodsky Institute of Chemical Kinetics and Combustion of Russian Academy of Science, Russia
Title: In situ delivery and production system of anti-cancer molecules with gene-engineered 
Shun’ichiro Taniguchi, Shinshu University School of Medicine, Japan
Title: Influence of mucoadhesivity on the bioavailability of nanoparticulate drug delivery systems
Ylenia Zambito, University of Pisa, Italy
Title: Systemic liver-targeting delivery of a novel DNA/RNA heteroduplex oligonucleotide via an enteral route
Chie Watanabe, Josai University, Japan
Title: Physicochemical and biophysical study of mechanisms the drugs bioavailability enhancement with new multifunctional delivery systems
Nikolay E. Polyakov, Voevodsky Institute of Chemical Kinetics and Combustion of Russian Academy of Science, Russia
Title: Designing ADME formulations with matching exposures to amorphous solid dosage forms
Aditya Tatavarti, Merck Sharp & Dohme Inc, USA
Title: Wound healing mats made of layer by layer coated nanoparticles and electrospun nanofibers
Gulcin Arslan Azizoglu, Ege University, Turkey
Title: In vitro model of diclofenac sodium gel delivery through pig skin
Enkelejda Goci, Aldent University, Albania
Title: Influence of formulation and freeze drying process variations on protein stability
Paritosh Pande, IMA Life North America and University of Connecticut, USA
Title: Valproic acid encapsulated biodegradable microneedles for treatment of androgenetic alopecia
Shayan Fakhraei Lahiji, Yonsei University, South Korea
Title: Therapeutic effects of trehalose liposomes against tumors along with apoptosis
Yoko Matsumoto, Sojo University, Japan

Day 2: June 25, 2019 (Tuesday)

Day 2 was initiated by Moderator: Elinaz Farokhi from San Diego State University, USA and the Keynote Forum included:

Mino R. Caira from University of Cape Town, South Africa
Angelita Rebollo from CIMI Paris, France
Rui Tamura from Kyoto University, Japan

Oral Presentations were held on Nanotechnology in Pharmaceutics and Drug delivery systemsPharmacovigilance and Drug SafetyTherapeutic Drug Carrier SystemsCellular Targeting and Intracellular DeliveryPharmaceutical Microbiology and BiotechnologyVaccine design and drug delivery technology

Day 2 Speakers with their Presentation Details:

Title: Nano- versus micro-particles for S-nitrosoglutathione formulation
Marianne Parent, Université de Lorraine, France
Title: Pseudomonas aeruginosa type 3 secretion system mediated antigen delivery for cancer immunotherapy
Toussaint Bertrand, University Grenoble Alpes, France
Title: Engineering novel selectivity into metalloantibodies germline-encoded precursor to the murine anti-S1P metalloantibody in E.coli and baculovirus-insect cell system
Elinaz Farokhi, San Diego State University, USA
Title: Discovery of novel bacterial genes encoding the enzymes acting on modified uracil/uridine derivatives and their use for gene therapy in cancer treatment
Jaunius Urbonavi?ius, Vilnius Gediminas Technical University, Lithuania
Title: Drug delivery to the skin: Nanostructures for the treatment of precancerous actinic keratosis
Silvia Tampucci, University of Pisa, Italy
Title: Liposomes as valuable drug delivery systems for siRNA and Hsp90 inhibitors to target triple negative breast tumors
Juliette Vergnaud-Gauduchon, Université Paris-Sud, France
Title: A RNA producing DNA hydrogel as a platform for a high performance RNA interference system
Nokyoung Park, Myongji University, South Korea
Title: Metal-organic framework nanoparticles preparation of sildenafil: A new window in the treatment of pulmonary arterial hypertension
Haissam Abou Saleh, Qatar University, Qatar
Title: Release and activity of the broad spectrum antibiotic Rifampicin from biodegradable polymer PLGA
Justine Fraser, The University of Strathclyde, UK
Title: Role of the optimal dynamic state and stabilized catalytic complex for rational design of pharmaceutical enzymes: Engineering of streptokinase with enhanced, fibrin-dependent activity
Farzin Roohvand, Pasteur Institute of Iran, Iran
Title: Pharmacovigilance: Aims, challenges and perspective
Razan Ghattas Mhanna, Lebanese International University, Lebanon
Title: Original Synthesis of natural acetogenins, fattyacids and lembehynes as a potential drugs for treatment of cancer and neurodegenerative diseases
Vladimir A. D’yakonov, Institute of Petrochemistry and Catalysis of RAS, Russia
Title: The nuclear membrane as a barrier to the action of anthracycline chemotherapeutics
Gulnihal Ozcan, Koc University Research Center for Translational Medicine, Turkey
Title: Global legal tools for pharmacovigilance and risk control
Eliana Silva De Moraes, Partner at Silva de Moraes Associes, France and Brazil
Title: Self-propelled objects with high autonomy for transportation
Satoshi Nakata, Hiroshima University, Japan

Poster Presentations held on Day 2 included presentation from various topics on pharmaceuticsdrug safetydrug deliveryNanotechnology in Pharmaceuticsand Drug delivery systemsPharmacovigilance and Drug SafetyTherapeutic Drug Carrier SystemsCellular Targeting and Intracellular DeliveryPharmaceutical Microbiology and BiotechnologyVaccine design and drug delivery technology,  Novel Developments In Drug Delivery SystemFormulation TechnologiesAdvanced Drug Delivery SystemsDrug Delivery Through BBBBiodrugsBiomolecules and Therapeutics and many more…

Poster Presenters with their Presentation Details:

Title: HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
Mamuka Kvaratskhelia, University of Colorado School of Medicine, USA
Title: Study of the capability of Chitosan-Glutathione nanoparticles to modulate redox state in human Chondrocytes
Roberto Diaz-Torres, National University of Mexico, Mexico
Title: The biomedical application of biogenic silver nanoparticles produced from Cotyledon orbiculata
Samantha Meyer, Cape Peninsula University of Technology, South Africa
Title: Nano-amorphous abiraterone acetate formulation with improved bioavailability and eliminated food effect
Tamás Jordán, NanGenex Inc, Hungary
Title: Dissolution study of drug release from biopolymer matrix tablets
Kevin Matzick, University of Pardubice, Czech Republic
Title: TAA-induced liver damage in KLF10 knockout mice
Azra Memon, Inha University, Republic of Korea
Title: Neuropeptide Y-based recombinant peptides improve bone loss in mice by regulating hematopoietic stem/progenitor cell mobilization
Hee Kyung Jin, Kyungpook National University, Republic of Korea
Title: Antitumor effects of retargeted AAV2 virus on ovarian cancer in vivo
Hyung Jun Ahn, Korea Institute of Science and Technology, South Korea
Title: Niosomal encapsulation of Curcumin: Characterization and its potential as a therapeutic intervention in asthma
Dinesh Kumar Chellappan, International Medical University, Malaysia
Title: Calotropis gigantea extract induces apoptosis through extrinsic/intrinsic pathways and reactive oxygen species generation in A549 and NCI-H1299 non-small cell lung cancer cells
Jiyon Lee, Konkuk University, Republic of Korea
Title: Kinetics of pentoxifylline release from hydrophilic, lipophilic and dual matrix tablets
Barbora Slezáková, University of Pardubice, Czech Republic
Title: Development of rotigotine nanoparticles and its effect on haloperidol induced Parkinsonian symptoms in rats
Subrat Kumar Bhattamisra, International Medical University, Malaysia
Title: Synthesis, evaluation and computational simulation of novel coumarin derivatives as potential acetylcholinesterase inhibitors
Haeil Park, Kangwon National University, Republic of Korea
Title: Characterization and validation of tumor cell-selective penetrating peptides
Angelita Rebollo, CIMI Paris, France
Title: Freshwater sapropel extract for use in medicine and pharmaceutics
Aneka Klavina, Rigas Stradi?š University, Latvia
Title: Fabrication and characterization of transdermal patch loaded with Ascorbic acid
Ahlam Zaid Alkilani, Zarqa University, Jordan
Title: Nanoemulsion–laden organogels of lidocaine as lipid–based systems for topical delivery
Rania Hamed, Al-Zaytoonah University of Jordan, Jordan
Title: Anti-cancer effect of Tuberatolide B in MDA-MB-231 cells through induction of ROS and inhibition of STAT3 pathway
Areumi Park, Korea Institute of Ocean science & Technology, Republic of Korea
Title: Protective effect of Bis (3-bromo-4,5-dihydroxybenzyl) ether against LPS-induced inflammatory response in RAW 264.7 macrophages through ROS-mediated ERK signaling pathway
Soo-Jin Heo, Korea Institute of Ocean science & Technology, Republic of Korea
Title: Saringosterol acetate suppressed hepatocelluar carcinoma growth and metastasis in a zebrafish xenograft model
Eun-A Kim, Korea Institute of Ocean science & Technology, Republic of Korea
Title: Molecular weight characterization of sodium carboxymethyl cellulose by advance polymer chromatography
Ekaterina Sobich, AbbVie Deutschland GmbH & Co. KG R&D, Germany
Title: Strategies to increase the passage of large molecules through the blood brain barrier
Charlotte Lombardi, Grenoble-Alpes University, France
Title: Peptide functionalized nanoparticles for the selective induction of apoptosis in target cells
Mervin Meyer, University of the Western Cape, South Africa
Title: Cell-free expression of a membrane antigen for vaccine uses
Geraldine Mayeux, University Grenoble Alpes, France
Title: Thermoresponsive in situ gelling systems for ophthalmic drug delivery
Concepción Renedo Laguna, University of Seville, Spain

Best poster awards was received by:

Rania Hamed, Al-Zaytoonah University of Jordan, Jordan
Mervin Meyer, University of the Western Cape, South Africa

Day 3: June 26, 2019 (Wednesday)

Moderator: Maria van Dongen from The Janssen Pharmaceutical Companies of Johnson & Johnson, Belgium has initiated the keynote session which included:

Ülo Langel from Stockholm University, Sweden
El Hassane Larhrib from University of Huddersfield, UK
Marlene Lúcio from  CF-UM-UP, Portugal
Amanda Silva Brun from CNRS, Université Paris-Diderot, France

Oral Presentation on Day 3 were held on Advances in Biotherapeutics-Drug Discovery and DevelopmentDrug discovery and ScreeningPharmaceutical Analysis and Quality Assurance , Pharmaceutical Research & Development sessions

Day 3 Speakers with their Presentation Details:

Title: Antibody-guided discovery of potent small-molecule fusion inhibitors of influenza virus
Maria van Dongen, The Janssen Pharmaceutical Companies of Johnson & Johnson, Belgium
Title: Targeting liver function to circumvent neuronal and cardiac dysfunctions linked to hyperhomocysteinemia
Nathalie Janel, University Paris Diderot, France
Title: Detection of “Hidden” drug resistance by the EZMTT assay
Benfang (Bennie) H. Ruan, Zhejiang University of Technology, China
Title: New indications for FDA-approved drugs: Selective inhibition of the growth of Helicobacter pylori by covalent allosteric regulation of urease
Fang Wu, Shanghai Jiao Tong University, China
Title: Chimeric antigen receptor(CAR)-T CELL; a biodrug as cancer therapeutic agent
Preeti Sharma, Satosh Medical College and Hospital, India
Title: Freshwater Sapropel as raw material in medicine and pharmaceutical production
Agris Auce, Rigas Stradins University, Latvia
Title: P-selectin targeted nanocarriers are efficient drug delivery systems to activated endothelium
Manuela Calin, Institute of Cellular Biology and Pathology “N. Simionescu”, Romania
Title: Development of novel leads for triple-negative breast cancer immunotherapy
Jing Yu, Shanghai Jiao Tong University, China
Title: Novel small molecules for PPARs modulation and their potential use for treatment of metabolic disorders
Antonio Laghezza, Università degli Studi di Bari “Aldo Moro”, Italy
Title: Caloric restriction and longevity
Bartolome Ribas Ozonas, Royal National Academy of Pharmacy, Institute of Spain. Madrid, Spain
Title: Synactix Inc and academic case studies of targeted therapy
Hong-yu Li, University of Arkansas for Medical Sciences, USA
Title: Liposomal encapsulation of silver nanoparticles suppresses nanoparticle-induced ROS and inflammation, and induces caspase-dependent apoptosis
Azeez Yusuf, Technical University Dublin, Ireland
Title: Development of substances with biological and pharmacological activity based on structural nucleus hybrids from phytochemical compounds like secondary metabolites
José Eduardo Cuéllar, Universidad Nacional de Colombia, Colombia
Title: Aspects of controlled-release dosage forms in veterinary medicine with emphasis on GRDF
Eran Lavy, Hebrew University of Jerusalem, Israel

With the successful completion of PDDS 2019 at Paris, France, Magnus Group takes the pleasure to announce its Upcomig Editions:

4th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PHARMA 2020) during April 27-29, 2020 at Dubai, UAE

5th Edition of Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2020) during June 15-17, 2020 at Rome, Italy

Details of upcoming Hematology Conferences :

Conference Name Place Date
Hematology Conference 2020 Orlando, USA October 29-31, 2020

2nd Edition of International Conference on Oncologyand Radiology 2018 Report:

Magnus Group Successfully completed “2nd Edition of  International Conference on Oncology and Radiology which was held in Rome, Italy, during September 17-19, 2018.

Cancer Conference 2018 witnessed an amalgamation of outstanding speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Oncology and Radiology. The extremely well-known conference hosted by Magnus Group was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing diverse countries around the world.

For ICOR 2018 Final ProgramClick Here

For ICOR 2018 Abstract Book: Click Here

For ICOR 2018 GalleryClick Here

Magnus Group is privileged to thank the Organizing Committee Members and Keynote Speakers for making their contributions in the form of very informative presentation

Lucio Miele, Louisiana State University Health Sciences Center, USA

Elizabeth Franzmann, Vigilant Biosciences, USA

Rossana Berardi, Universita Politecnica delle Marche, Italy

Tamara Lah Turnsek, National Institute of Biology, Slovenia

Jozef Sabol, Department of Crisia Management, PACR, Czech Republic


ICOR 2018 Speaker Line Up:

Victoria Seewaldt, City of Hope Comprehensive Cancer Center, USA
Annika Lindstrom, CKF Dalarna, Uppsala University, Sweden 
Francesco Izzo, National Cancer Institute of Naples, Italy
Jerome Paillassa, Centre Hospitalier Universitaire d'Angers, France
Yaoru Huang, Taipei Medical University Hospital, Taiwan
Igor Pogrebniakov, SRI of clinical and experimental radiology of N.N.Blokhin CRC, Russian Federation
Erwin Danil Yulian, University of Indonesia, Indonesia
Surajit Pathak, Chettinad Academy of Research and Education, India
Joshua D. Palmer, Ohio State University Wexner Medical Center, United States
Mark S. Parker, VCU Medical Center, USA 
Francesco Giovinazzo, University Hospital of Southampton NHS Foundation Trust, UK
Myron R. Szewczuk, Queen’s University, Canada
Giulia Zumbo, Southampton General Hospital, Uk
Marina De Rosa, University of Naples Federico II, Italy
Jose Carlos dos Santos, Universitatsklinikum Heidelberg, Germany
Chiu Sai Yiu Richard, Hong Kong Baptist Hospital, Hong Kong
Neeraj Jain, Sri Guru Ram Das University of Health Science, India 
Ivana Jovcevska, University of Ljubljana, Slovenia
Cagri Oner, Maltepe university, Turkey
Bahadir Batar, Namik Kemal University School of Medicine, Turkey 
Ocung guido, Makerere University, Uganda
Jalil Ur Rehman, Baluchistan University of Information Technology Engineering , Managements and Science, Pakistan

ICOR 2018 Poster Presenters:

Joo Hee Yoon, The Catholic University of Korea, Korea, Republic of
Martina Seifrtova, Charles University, Czech Republic
Masaru Shimada, Yokohama City University, Japan
Radim Havelek, Charles University, Czech Republic
Jung Hwan Yoon, The Catholic University, Korea, Republic of
Miyoung Park, The Catholic University of Korea, Korea, Republic of
Chae Ri Park, Asan medical center (AMC), Korea, Republic of
Youn Kyoung Jeong, Korea Institute of Radiological & Medical Sciences, Korea, Republic of
Jan Marek, Faculty Hospital Hradec Kralove, Czech Republic

Magnus Group would like to  thank all the participants for their wonderful involvement towards the event which helped us for successful execution of this event.

Recommended Cancer ConferencesCancer Conferences 2019 | Oncology Conferences | Oncology Conferences 2019 | Radiology Conferences

After the successful completion of "2nd Edition of International Conference on Oncology and Radiology(ICOR 2018conference, we are pleased to announce our next upcoming conference “3rd Edition of International Cancer Conference" (ICC 2019) which is going to be held during September 23-25, 2019 in London, UK.

                                                Mark your calendars for the upcoming ICC 2019 conference; We are hoping to see you soon!

Conference Schedule




Opening Ceremony and Introduction


Keynote Session I


Refreshment Break


Keynote Session II




Break Out Session I


Refreshment Break


Break Out Session II


Keynote Session III


Refreshment Break


Break Out Session III



13:30 15:00

Poster Presentations


Refreshment Break


Break Out Session IV


Prize Distribution and Closing Ceremony

Watch Past Conference Review

Photo Gallery (Our Past Events)